SCHEMBL20031603

SCHEMBL20031603

CC1COC(Cn2cncc2Br)(c2ccc(Oc3ccc(C(F)(F)F)cc3)cc2Cl)O1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 18/20 0.37
THRB P10828 1/20 0.37
CYP21A2 P08686 9/20 0.33
CYP19A1 P11511 9/20 0.33
CYP17A1 P05093 8/20 0.33
CYP11B1 P15538 7/20 0.33
NR1I2 O75469 2/20 0.32
LMNA P02545 2/20 0.32
HSP90AA1 P07900 2/20 0.32
CHRM2 P08172 2/20 0.32
ADRA2A P08913 2/20 0.32
TSHR P16473 2/20 0.32
ADRA2B P18089 2/20 0.32
SLC6A2 P23975 2/20 0.32
HTR2A P28223 2/20 0.32
SLC6A4 P31645 2/20 0.32
SLC6A3 Q01959 2/20 0.32
KCNH2 Q12809 2/20 0.32
CYP51A1 Q16850 2/20 0.32
FYN P06241 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20031604 0.90 CYP3A4 (0.36) CYP3A4THRBCYP21A2CYP19A1CYP17A1
SCHEMBL20031127 0.87 FNTA (0.33) SLC6A2HTR2ASLC6A4SLC6A3KCNH2
SCHEMBL21631894 0.83 CYP3A4 (0.44) CYP3A4THRBCYP21A2CYP19A1CYP17A1
SCHEMBL21632262 0.78 CYP3A4 (0.38) CYP3A4THRBCYP21A2CYP19A1CYP17A1
SCHEMBL21887073 0.75 CYP3A4 (0.47) CYP3A4THRBCYP21A2CYP19A1CYP17A1
SCHEMBL30611136 0.75 CYP3A4 (0.47) CYP3A4THRBCYP21A2CYP19A1CYP17A1
SCHEMBL20031605 0.74 FNTA (0.32) HTR2ASLC6A4KCNH2NPBWR1FNTA
SCHEMBL21632114 0.74 NPBWR1 (0.31) HTR2ASLC6A4KCNH2NPBWR1FNTA
SCHEMBL24061653 0.73 HMOX1 (0.54) CYP3A4CYP21A2CYP19A1CYP17A1CYP11B1
Difenoconazole SCHEMBL15932941 0.73 CYP3A4 (0.68) CYP3A4THRBCYP21A2CYP19A1CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200029563-A1 NOVEL 5-SUBSTITUTED IMIDAZOLYLMETHYLDIOXOLANE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2020-01-30 US disclosed
WO-2018060088-A1 5-SUBSTITUTED IMIDAZOLYLMETHYLDIOXOLANE DERIVATIVES AS FUNGICIIDES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2018-04-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200029563-A1 NOVEL 5-SUBSTITUTED IMIDAZOLYLMETHYLDIOXOLANE DERIVATIVES PIP5K1B, PIP5K1A, PIP5K1C CYP3A4 2019/4885THRB 3255/4885CYP21A2 4090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.